Uncategorized Bacteriophage therapy to treat primary sclerosing cholangitis 25 Jun 2023 Another interesting study on phage therapy : "Bacteriophage therapy against pathological Klebsiella pneumoniae ameliorates the course of primary sclerosing cholangitis" Nature Communications volume 14, Article number: 3261 (2023) Abstract Primary sclerosing cholangitis (PSC) is characterized by progressive…
Uncategorized Phage Therapy: An Observation Study 10 Jun 2023 A retrospective, observational study of 12 cases of expanded access customized phage therapy: production, characteristics, and clinical outcomes Clinical Infectious Diseases, ciad335 Abstract Background Antibiotic resistance (AMR) is undermining modern…
Uncategorized Non-alcoholic fatty liver disease: Bacteriophages to treat Klebsiella pneumoniae 6 Jun 2023 Abstract Our previous studies have shown that high alcohol-producing Klebsiella pneumoniae (HiAlc Kpn) in the intestinal microbiome could be one of the causes of non-alcoholic fatty liver disease (NAFLD). Considering antimicrobial resistance of K.…
Uncategorized Advancements in bacteriophage therapies 3 Jun 2023 Advancements in bacteriophage therapies and delivery for bacterial infection DOI: 10.1039/D2MA00980C (Review Article) Mater. Adv., 2023, 4, 1249-1257 Abstract Having co-evolved with bacteria over hundreds of millions of years, bacteriophage are effective killers of…
PHAGElogist 